Terms: = Liver cancer AND uPA AND Clinical Outcome
3 results:
1. Synergistic antimetastatic effect of cotreatment with licochalcone A and sorafenib on human hepatocellular carcinoma cells through the inactivation of MKK4/JNK and upa expression.
Wu MH; Chiu YF; Wu WJ; Wu PL; Lin CY; Lin CL; Hsieh YH; Liu CJ
Environ Toxicol; 2018 Dec; 33(12):1237-1244. PubMed ID: 30187994
[TBL] [Abstract] [Full Text] [Related]
2. Lectin BS-I inhibits cell migration and invasion via AKT/GSK-3β/β-catenin pathway in hepatocellular carcinoma.
Jian Q; Yang Z; Shu J; Liu X; Zhang J; Li Z
J Cell Mol Med; 2018 Jan; 22(1):315-329. PubMed ID: 28922551
[TBL] [Abstract] [Full Text] [Related]
3. Tumor cell dissemination in colon cancer does not predict extrahepatic recurrence in patients undergoing surgery for hepatic metastases.
Schoppmeyer K; Frühauf N; Oldhafer K; Seeber S; Kasimir-Bauer S
Oncol Rep; 2006 Feb; 15(2):449-54. PubMed ID: 16391868
[TBL] [Abstract] [Full Text] [Related]